Elevance Health Inc. (NYSE:ELV)

The solvency profile exhibits a general stability in leverage ratios alongside a significant and consistent decline in interest coverage capacity over the analyzed period.

Debt-to-Equity and Debt-to-Capital Ratios

Debt to equity remained relatively stable between 0.64 and 0.68 from March 2022 through September 2024. A notable peak occurred on December 31, 2024, reaching 0.76, before stabilizing between 0.69 and 0.73 through March 2026. Similarly, the debt to capital ratio maintained a tight range around 0.39 to 0.41 for the majority of the period, with a marginal increase to 0.42 and 0.43 toward the end of 2024 and into 2025.

Debt-to-Assets and Financial Leverage

The debt to assets ratio showed minimal variance, holding steady at 0.23 for the first two years. A slight upward shift was observed in late 2024, peaking at 0.27, and subsequently averaging 0.25 to 0.26. Financial leverage fluctuated within a narrow band between 2.66 and 2.92, showing no definitive long-term directional trend, though it ended the period at 2.87.

Interest Coverage Trend

A pronounced downward trend is evident in the interest coverage ratio. Starting at 11.01 in March 2022, the ratio declined steadily, falling below 9.0 in September 2023 and continuing a consistent descent to 5.39 by March 2026. This represents a substantial reduction in the margin of safety available to meet interest obligations from operating earnings.

While the structural capital components—represented by the debt-to-equity and debt-to-assets ratios—remain largely controlled, the deteriorating interest coverage suggests an increase in interest expenses relative to earnings or a compression of operating income over the analyzed timeframe.

The solvency profile of the organization exhibits a general trend of increasing leverage from March 2022 through March 2026, characterized by a steady rise in total liabilities alongside a consistent expansion of the equity base.

Total Debt Trajectory

Total debt increased from 23,255 million US$ in March 2022 to 31,842 million US$ by March 2026. The growth was relatively gradual until the fourth quarter of 2024, which saw a significant surge from 27,148 million US$ in September to 31,232 million US$ in December. Following this peak, debt levels remained elevated, fluctuating between 30,003 million US$ and 32,102 million US$ through the end of the period.

Shareholders' Equity Evolution

Shareholders' equity demonstrated an overall upward trend, rising from 35,975 million US$ in March 2022 to 43,902 million US$ in March 2026. A temporary contraction was observed in December 2024, where equity dropped to 41,315 million US$ from a previous high of 43,775 million US$ in September 2024. However, a recovery followed immediately, with equity stabilizing above 43,000 million US$ throughout 2025 and early 2026.

Debt to Equity Ratio Dynamics

The debt to equity ratio remained stable within a narrow band of 0.64 to 0.68 between March 2022 and September 2024. A sharp increase to a peak of 0.76 occurred in December 2024, coinciding with the simultaneous spike in total debt and the dip in shareholders' equity. In the subsequent periods, the ratio normalized but settled at a higher baseline than the initial years, fluctuating between 0.69 and 0.73 from June 2025 to March 2026.

The solvency profile exhibits a controlled increase in leverage over the analyzed period from March 31, 2022, to March 31, 2026. While both absolute debt and total capital levels have risen, the proportion of debt relative to total capital has remained relatively stable, indicating a disciplined approach to capital structure management.

Total Debt Trends

A gradual upward trajectory is observed in total debt, rising from 23,255 million US dollars in March 2022 to 31,842 million US dollars by March 2026. A notable acceleration in borrowing occurred between June 30, 2024, and December 31, 2024, where debt increased from 27,686 million to 31,232 million US dollars. Following this spike, the debt levels stabilized, oscillating between 30,000 and 32,100 million US dollars through the end of the period.

Total Capital Expansion

Total capital demonstrates consistent growth, moving from 59,230 million US dollars in March 2022 to 75,744 million US dollars in March 2026. This steady expansion suggests a continuous increase in the company's overall funding base, which has served to offset the increase in total debt and maintain solvency stability.

Debt to Capital Ratio Analysis

The debt to capital ratio remained within a narrow range of 0.38 to 0.43 throughout the period. For the first two years, the ratio fluctuated minimally between 0.39 and 0.41. A peak of 0.43 was reached in December 2024, coinciding with the sharp increase in total debt. However, the ratio subsequently corrected and stabilized at 0.42 by the final quarters of 2025 and early 2026. The stability of this ratio suggests that the increase in debt was matched by a proportional growth in the total capital base, preventing a significant deterioration in the solvency position.

An analysis of the solvency metrics reveals a period of steady balance sheet expansion accompanied by a moderate increase in leverage. While total assets grew consistently over the observed period, total debt experienced a more volatile upward trajectory, leading to a slight elevation in the overall debt-to-assets ratio.

Total Debt Trends

Debt levels remained relatively stable between March 2022 and December 2023, fluctuating within the 23 billion to 25 billion range. A significant acceleration in borrowing occurred throughout 2024, with total debt rising from 26.45 billion in March to a peak of 31.23 billion by December. Following this surge, debt levels stabilized between 30 billion and 32 billion through March 2026.

Total Asset Growth

A consistent upward trend is observed in total assets, which increased from 100.49 billion in March 2022 to 125.83 billion by March 2026. This growth indicates a steady expansion of the organization's resource base, which has served to mitigate the impact of increased borrowing on the solvency ratio.

Debt to Assets Ratio Analysis

The debt-to-assets ratio exhibited high stability at 0.23 for the majority of 2022 and 2023. A gradual increase began in early 2024, peaking at 0.27 in December 2024, directly correlating with the spike in total debt. In the subsequent periods, the ratio moderated and stabilized between 0.25 and 0.26, suggesting that asset growth has largely kept pace with the increased debt load.

Analysis of the solvency metrics reveals a period of steady balance sheet expansion characterized by a general increase in both total assets and shareholders' equity, while the financial leverage ratio remained within a narrow and stable corridor.

Asset Growth Trends

Total assets exhibited a consistent upward trajectory, rising from 100,486 million USD in March 2022 to 125,827 million USD by March 2026. This represents a sustained expansion of the company's resource base throughout the observed timeframe.

Equity Dynamics

Shareholders' equity generally trended upward from 35,975 million USD in March 2022 to 43,902 million USD in March 2026. A notable contraction is observed in December 2024, where equity dropped to 41,315 million USD from a peak of 43,775 million USD in September 2024, before returning to a growth trend in 2025.

Financial Leverage Analysis

The financial leverage ratio fluctuated between a maximum of 2.92 in March 2023 and a minimum of 2.66 in September 2024. The ratio demonstrates a mean-reverting pattern, oscillating around the 2.8x level. The spike in leverage to 2.83 in December 2024 was directly correlated with the reduction in shareholders' equity during that quarter. By March 2026, the ratio settled at 2.87, indicating a stable capital structure relative to the historical average of the period.

The solvency profile of Elevance Health Inc. demonstrates a consistent weakening of its capacity to service interest obligations from March 2022 through March 2026. The interest coverage ratio experienced a sustained decline throughout the observed period, falling from a peak of 11.01 to 5.39.

Earnings Before Interest and Tax (EBIT) Performance

Operating earnings exhibit significant quarterly volatility with a recurring seasonal pattern, typically reaching lows in the fourth quarter of each year. Although strong peaks were recorded in March 2024 ($3,204 million) and March 2025 ($3,141 million), the year-end figures show a marked downward trend, with the December 31, 2025, value of $581 million representing the lowest point in the analyzed timeframe.

Interest Expense Trajectory

A steady and uninterrupted increase in interest expenses is observed. Costs rose from $201 million in March 2022 to $357 million by March 2026. This consistent upward trend indicates an increase in the company's debt servicing costs over the four-year period.

Interest Coverage Ratio Analysis

The interest coverage ratio has undergone a systematic erosion driven by the convergence of rising interest expenses and unstable operating earnings. The ratio remained above 10.0 during the first three quarters of 2022 but declined steadily thereafter. Notable benchmarks include a drop below 9.0 in September 2023 and a further decline below 6.0 by September 2025, concluding at 5.39 in March 2026. This trend reflects a diminishing margin of safety regarding the company's ability to cover its interest payments from operating profits.